Abstract
INTRODUCTION
Acute limb ischemia (ALI) constitutes a medical emer gency defined as a severely reduced perfusion of the leg resulting from a total or subtotal arterial occlusion, with symptoms debuting < 14 d prior to presentation. It has an incidence of around 140/million/year and a prevalence of 1%3% [1, 2] . Depending on the severity of symptoms, patients can be grouped according to the Rutherford classification of lower extremity ischemia [3] . Although significant advances have been made in the treatment of ALI, most of the studies still report an amputation rate of 10%30% at 30 d [46] . Patients with thromboembolic ALI are especially at high risk for major amputation and death due to sepsis and multiorgan dysfunction. Such patients are usually older than 75 years and show further comorbidities, including atrial fibrillation and history of heart failure [7] . Previous studies demonstrated the superiority of catheterdirected thrombolysis (CDT) compared to surgical treatment in regard to amputationfree sur vival in patients presenting with ALI [6, 8] . However, this technique has its clear limitations in patients with an increased bleeding risk. Therefore, percutaneous mechanical thrombectomy systems have emerged in the last years as a valid therapeutic option in patients with ALI [9] . One such system, the Rotarex ® S mechanical debulking catheter (Straub Medical, Wangs, Switzerland) is based on mechanical fragmentation and simulta neous aspiration of occlusion material, thus transpor ting the debris out of the patient. Several studies have shown a very high success rate of Rotarex ® S alone or in combination with drugcoated balloons in terms of establishing vessel patency in patients with ALI [5] . However, operators should be cautious when using the 6 French (6F) Rotarex ® S catheter in arteries belowthe knee because this catheter system is limited to vessel diameters of ≥ 3mm and might cause dissection or perforation when used in smaller diameter arteries. Herein, we present the clinical safety and effectiveness of the 6F Rotarex ® S system in a miniseries of seven patients with acute lower limb ischemia affecting their crural arteries.
MATERIALS AND METHODS
The files of 102 patients with thrombotic occlusions of the lower extremities between January 2015 and December 2017 at the Department of Cardiology and Vascular Medicine, Academic Teaching Hospital Weinheim were examined. In seven patients, the Rotarex ® S catheter was used in the proximal segment of the crural arteries, and the data from these patients were further used for the analysis. In the remaining 95 patients, the Rotarex ® S catheter was used for mechanical thrombectomy in iliac and femoropopliteal arteries. The study was approved by the local ethics committee of the University Hospital Heidelberg (S100/2017). Retrospective data were collected in accordance with the Declaration of Helsinki.
Interventional treatment
All patients received a bolus of 2500 U of heparin after placement of a 6F sheath introducer in the femoral artery. During interventional treatment, all patients also received heparin to reach an activated clotting time of > 300 s. If necessary, patients also received 500 mg aspirin during and 300 mg clopidogrel during or after the interventional procedure. If additional thrombolysis was deemed necessary, a bolus of 10 mg recombinant tissue plasminogen activator (rtPA) was administrated after placement of the dedicated thrombolysis catheter (Unifuse catheter, AngioDynamics, Netherlands). Postprocedural rtPA was continuously administered at an infusion rate of 1 mg/h for 618 h, adding heparin to achieve partial thromboplastin time of 5060 s.
Statistical analysis
Continuous variables are presented as numbers, providing the corresponding range of each variable. Categorical variables are represented as percentages. Measures of the vessel diameters were conducted using ImageJ software (version 1.50, NIH, Bethesda, MD, United States).
RESULTS

Demographic characteristics and procedural data
We present a mini-series of seven patients (Patient A-G). Baseline characteristics of our patients are provided in Table 1 . Patients were referred to our department with symptoms of ALI with new onset of pain, paleness and pulselessness during the last 17 ± 13 h. Duplex sonography revealed thrombotic occlusion of the common femoral 
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® S catheter thrombectomy in crural arteries maining 95 patients who received Rotarex ® S catheter thrombectomy in iliac and femoropopliteal vessels, it should be noted that Rotarex ® S efficacy was present in 93 of 95 cases (98%), whereas vessel dissection or perforation was observed in two of 95 cases (2%), which in both cases was treated using an endovascular approach by prolonged balloon inflation and by place ment of a stent, respectively.
Size of the treated crural arteries
The size of the proximal crural arteries varied between 3.2 and 4.0 mm, whereas the size of the midportion of the crural arteries varied between 2.5 and 3.5 mm. An overview of the diameters of the proximal and midportions of the crural arteries of our patients, where mechanical thrombectomy was performed, can be app reciated in Table 3 .
Post-procedural data
Ischemic symptoms promptly resolved in all patients after the index procedure. Duplex sonography on the following day exhibited patency of all of the treated crural arteries. In addition, further clinical course was artery (CFA) in two of seven cases (29%), and of the distal superficial femoral artery (SFA) and of the popliteal artery in the remaining five of seven cases (71%). The localization of arterial occlusion was confirmed in all cases by digital subtraction angiography. Mechanical thrombectomy was performed in all cases using a 6F Rotarex ® S catheter and was combined by local lysis in five of seven cases (71%). Rotarex ® S catheter throm bectomy was performed in the CFA and in the SFA in two of seven cases (29%), and in the SFA and in the popliteal artery in the remaining five of seven cases (71%). Additional Rotarex ® S catheter thrombectomy due to remaining thrombus formation with no reflow in the crural arteries was performed in the anterior tibial artery in two of seven cases (29%), in the tibiofibular tract and posterior tibial artery in two of seven cases (29%) and in the tibiofibular tract and fibular artery in the remaining three of seven cases (43%)( Table 2 ).
Efficacy and safety data
In all seven cases, 6F Rotarex ® S catheter thrombectomy resulted in vessel patency, whereas no vessel dissections or perforations were observed. Compared to the re 
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® S catheter thrombectomy in crural arteries thrombectomy) were shown to be useful alone or associated with the use of additional thrombolytics or local thrombolysis (combined mechanical and phar macologic thrombectomy) for the management of patients with ALI. The main advantage of mechanical thrombectomy consists of the reduction of thrombotic burden, which reduces or even avoids the need for local thrombolysis. This is of major importance, particularly in patients with contraindication to thrombolysis due to high bleeding risks. Many mechanical thrombectomy devices are cur rently used for the endovascular treatment of ALI. The ThromCat XT catheter device consists of an atraumatic tip and a flexible steel helix and can provide an effective aspiration capacity of 0.63 mL/s even in vessels with relative large diameters [10] . However, due to the small aspiration ports of this catheter system, it is limited to the treatment of fresh arterial occlusions, as it is difficult for the system to aspirate partially organized thrombotic material. The AngioJet (Possis Medical, Minneapolis, Minnesota, United States) on the other hand, is a combined pharmacologic and mechanical thrombectomy system, which is dedicated to peripheral interventions and uses active aspiration and Power Pulse™ lytic uneventful in all seven patients, who were discharg ed within three days after mechanical thrombectomy. Five of seven (71%) patients were diagnosed with atrial fibrillation and were put on triple anticoagulation with 100 mg aspirin, 75 mg clopidogrel and oral anti coagulation for 4 wk, and were then continued with oral anticoagulation. The remaining two patients were treated with 100 mg aspirin and 75 mg clopidogrel for 3 mo and were then put on 100 mg aspirin daily. Representative images of our patients (Patient AC) can be appreciated in Figures 14.
DISCUSSION
ALI is a serious medical condition that requires rapid diagnosis and prompt initiation of appropriate treat ment. Depending on the clinical presentation and anatomy of the lesion, either an endovascular appro ach or a surgical therapy may be chosen. CDT is the classical method employed in the treatment of ALI. Mechanical thrombectomy techniques, on the other hand, represent a relatively new treatment in patients with ALI. Various devices using different mechanisms of action, (i.e., fragmentation, aspiration or rheolytic Several studies have demonstrated the efficacy of this system in the treatment of patients with ALI [1418] . In this regard, a high success rate of > 98% was reported in a recent study, which elegantly demonstrated that purely mechanical thrombectomy by the Rotarex ® S system was safer and more effective than thrombolysis, which was associated with higher rates of major bleedings, longer hospitalization durations and higher costs [19] . Potential complications associated with the Rotarex ® S endovascular system is peripheral embolization of thrombotic debris in peripheral foot arteries (in most of the cases after additional balloon angioplasty and not directly related to Rotarex ® S thrombectomy) and vessel dissection or perforation in smaller vessels. Particularly in vessels smaller than 3 mm in diameter, perforation may occur due to complete filling of the vessel by the catheter, which may eventually suck the vessel wall into the side windows of the catheter head. Although such complications can in most cases be treated by prolonged balloon inflation or by stent placement without requiring surgical action [16, 20] , the use of the 6F Rotarex ® S system delivery to remove the thrombus and restore blood flow [11] . It should be noted that only observational, non randomized data are available for such devices, including the Rotarex ® S system, whereas no direct comparisons for different thrombectomy devices have been reported so far.
The Rotarex ® S system is a purely mechanical en dovascular thrombectomy device (Straub Medical AG, Switzerland) [12, 13] . The system consists of an external drive system, which is connected to the Rotarex ® S catheter via a magnetic clutch. Inside the catheter tube, a helix transmits the rotation from the drive system to the catheter head, which can rotate with up to 60000 rpm, thus creating a powerful vortex to debulk all detachable occlusion material from the vessel. The frag mented debris is subsequently aspirated through side slits in the catheter head. The inner helix simultaneously creates a strong suction force, following the Archimedes principle, and finally transports the fragmented material into an external collecting bag. The Rotarex ® S catheter is currently available in three sizes, including 6F, 8F and 10F, and is inserted over a dedicated 0.018 guidewire. The aspiration efficacy is approximately 0.75 mL/s for is not currently generally recommended for crural arteries in the current literature [21] . In this regard, the use of the Rotarex ® S has been reported only in a relatively small number of patients with ALI involving below the knee vessels (n = 4 in the study of Stanek et al [18] ). To the best of our knowledge the present study is the first in the current literature, which in detail describes the efficacy and safety of the 6F Rotarex ® S system in a miniseries of seven patients, who were all treated for ALI in the proximal or mid-part of relatively big crural arteries with good angiographic and clinical results. Although no vascular complications in terms of dissection or perforation occurred in the crural arteries, the use of the 6F Rotarex ® S debulking system should be performed with caution in crural arteries.
In conclusion, mechanical debulking using the 6F Rotarex ® S catheter system may be a safe and effective treatment option in case of thrombotic or thrombo embolic occlusion of the proximal and mid portion of crural arteries in patients presenting with ALI, especially when local thrombolysis needs to be avoided due to increased bleeding risk.
ARTICLE HIGHLIGHTS
Research background
Endovascular treatment of acute limb ischemia (ALI) is increasingly gaining importance in older and multimorbid patients, compared to conventional surgical techniques. The Rotarex ® S debulking system is one such endovascular device, which can be used for catheter-assisted thrombectomy in ALI. However, the use of the 6 French (6F) Rotarex ® S system is not generally recommended for crural arteries in the current literature.
Research motivation
Limited data exist to date on the efficacy and safety of the 6F Rotarex ® S system for thrombectomy in crural arteries.
Research objectives
Our study aimed to examine whether the 6F Rotarex ® S system can be used effectively and safely for endovascular thrombectomy of crural arteries in patients with ALI.
Research methods
Retrospective analysis of all patients who were referred to our department for endovascular thrombectomy dues to ALI between January 2015 and December 2017.
Research results
We identified seven patients who underwent endovascular Rotarex ® S catheter thrombectomy in crural arteries due to remaining thrombus formation with no reflow. In two cases, thrombectomy was performed in the anterior tibial artery, in another two cases, in the posterior tibial artery and in the remaining three cases, in the fibular artery. In all seven cases, treatment resulted in restoration of the blood flow to the foot arteries, resolving ischemic symptoms. Vessel dissection or perforation did not occur in any of the seven cases..
Research conclusions
Endovascular thrombectomy using the 6F Rotarex ® S catheter system may be safe and effective for the treatment of thrombotic occlusion of the proximal and mid portion of crural arteries. In particular, patients with high bleeding risk may profit from such a "mechanical only" treatment option without the need for additional thrombolysis.
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